As the basketball frenzy that accompanies March Madness draws to the fever pitch of the Final Four, it brings to mind that basketball is a high contact sport.

NEW YORK, NY–(Marketwire -03/28/12)- Biotechnology stocks have been on an impressive run this year as favorable legislation out of Washington is allowing biotech companies of all sizes to more easily navigate regulations. Five Star Equities examines the outlook for companies in the Biotechnology industry and provides equity research on Advanced Cell Technology Inc

Nature | Health A Monsignor and Officer for Studies at the Pontifical Academy for Life called the cancellation a “sad event.” Attendees are set to receive an official explanation March 26, 2012| By Ewen Callaway of Nature magazine The Vatican has abruptly cancelled a controversial stem-cell conference that was set to be attended by the Pope next month. The Third International Congress on Responsible Stem Cell Research, scheduled for 25-28 April, was to focus on clinical applications of adult and reprogrammed stem cells

Weve heard of people freezing their eggs, blood and stem cells for use later on, but a health service startup is now enabling patients to freeze their own skin cells for potential future use in diagnostics, therapeutics and regenerative medicine techniques. Next Healthcare Inc.s goal is to enable personalized healthcare by providing skin and stem cell banking directly to patients through their medical professional. Technologies that utilize human skin cells and stem cells are rapidly evolving, the company says on its website.

SACRAMENTO (KABC) — Eight years ago voters agreed to fund California’s stem cell agency, hoping it would yield new treatments for various conditions.

SUNRISE, Fla., March 22, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc. (OTCBB:BHRT.OB – News), a company focused on developing stem cell therapies for heart disease, previously announced that they entered into an agreement with Stemlogix, LLC, a veterinary regenerative medicine company, to provide additional cellular products and services to the veterinary market

SACRAMENTO, Calif. (KGO) — Stem cells are the focus of debate in Sacramento where an effort is underway to use more than $1 billion in voter-approved bonds to continue experiments that may one day cure disease. Major medical breakthroughs take time, but as public money for stem cell research is spent down, the pressure to cure something is going up

Written by Nannette Miranda, ABC7 SACRAMENTO, CA – The California Institute for Regenerative Medicine, CIRM, is about to enter a crucial stage in stem cell research: going to clinical trials. The most promising experiments could cure: diabetes, HIV, sickle cell and blindness in the elderly

CLEARWATER, FL–(Marketwire -03/19/12)- Biostem U.S., Corporation (OTCQB: BOSM.PK – News) (Pinksheets: BOSM.PK – News) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, announced today the addition of Perinatologist Sanford M. Lederman, MD to its Scientific and Medical Board of Advisors (SAMBA).

LOS ANGELES, Calif. – The creation of California’s stem cell agency in 2004 was greeted by scientists and patients as a turning point in a field mired in debates about the destruction of embryos and hampered by federal research restrictions

LOS ANGELES (AP) The creation of California’s stem cell agency in 2004 was greeted by scientists and patients as a turning point in a field mired in debates about the destruction of embryos and hampered by federal research restrictions. The taxpayer-funded institute wielded the extraordinary power to dole out $3 billion in bond proceeds to fund embryonic stem cell work with an eye toward treatments for a host of crippling diseases

SUNRISE, Fla., March 15, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc.

WASHINGTON, March 13, 2012 /PRNewswire/ — TEDMED, www.TEDMED.com, the annual gathering where science, medical and technology leaders focus on “imagination, innovation and inspiration” to advance the art of health and medicine, today announced two new programs that will vastly increase the size and scope of its audience.

LOS ANGELES Researchers at the UCLA stem cell center and the departments of chemistry and biochemistry and pathology and laboratory medicine have identified, for the first time, a generic way to correct mutations in human mitochondrial DNA by targeting corrective RNAs, a finding with implications for treating a host of mitochondrial diseases. Mutations in the human mitochondrial genome are implicated in neuromuscular diseases, metabolic defects and aging.

Public release date: 12-Mar-2012 [ | E-mail | Share ] Contact: Kim Irwin kirwin@mednet.ucla.edu 310-206-2805 University of California – Los Angeles Health Sciences Researchers at the UCLA stem cell center and the departments of chemistry and biochemistry and pathology and laboratory medicine have identified, for the first time, a generic way to correct mutations in human mitochondrial DNA by targeting corrective RNAs, a finding with implications for treating a host of mitochondrial diseases. Mutations in the human mitochondrial genome are implicated in neuromuscular diseases, metabolic defects and aging. There currently are no methods to successfully repair or compensate for these mutations, said study co-senior author Dr.

Public release date: 11-Mar-2012 [ | E-mail | Share ] Contact: Kim Irwin kirwin@mednet.ucla.edu 310-206-2805 University of California – Los Angeles Health Sciences UCLA stem cell researchers have shown that insulin and nutrition keep blood stem cells from differentiating into mature blood cells in Drosophila, the common fruit fly, a finding that has implications for studying inflammatory response and blood development in response to dietary changes in humans. Keeping blood stem cells, or progenitor cells, from differentiating into blood cells is important as they are needed to create the blood supply for the adult fruit fly. The study found that the blood stem cells are receiving systemic signals from insulin and nutritional factors, in this case essential amino acids, that helped them to maintain their “stemness,” said study senior author Utpal Banerjee, professor and chairman of the molecular, cell and developmental biology department in Life Sciences and a researcher with the Eli and Edythe Broad Center of Regenerative Medicine at UCLA.

Newswise UCLA stem cell researchers have shown that insulin and nutrition keep blood stem cells from differentiating into mature blood cells in Drosophila, the common fruit fly, a finding that has implications for studying inflammatory response and blood development in response to dietary changes in humans. Keeping blood stem cells, or progenitor cells, from differentiating into blood cells is important as they are needed to create the blood supply for the adult fruit fly. The study found that the blood stem cells are receiving systemic signals from insulin and nutritional factors, in this case essential amino acids, that helped them to maintain their stemness, said study senior author Utpal Banerjee, professor and chairman of the molecular, cell and developmental biology department in Life Sciences and a researcher with the Eli and Edythe Broad Center of Regenerative Medicine at UCLA.

CLEARWATER, FL–(Marketwire -03/12/12)- Biostem U.S., Corporation (OTCQB: BOSM.PK – News) (Pinksheets: BOSM.PK – News) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, announced today the addition of cardiothoracic surgeon Thomas W. Prendergast, M.D.

TORONTO, ONTARIO–(Marketwire -03/09/12)- The newest player in the regenerative medicine (RM) field in Canada is taking a collaborative approach to commercializing stem cell and biomaterials products. The Centre for Commercialization of Regenerative Medicine (CCRM) has created an industry consortium that is working together to address real-life bottlenecks in their RM product pipelines.

A new type of stem cell-seeded patch has shown promising results in promoting healing after a heart attack, according to a study released today in the journal STEM CELLS Translational Medicine. Durham, NC (PRWEB) March 07, 2012 Ischemic heart disease, caused by vessel blockage, is a leading cause of death in many western countries.